INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Results

76,378 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
6
FK
Feeley KevinCHIEF FINANCIAL OFFICER
WGSGeneDx Holdings Corp.
Option exercise
M—
2,462 sh
Jun 9, 2026Jun 11, 2026
Page 832 of 1910
← PrevNext →
traded Jun 9, 2026
+2d
SEC Form 4

Evidence

5
SN
Sweeny NicoleChief Commercial Officer
KALVKalVista Pharmaceuticals, Inc.
Disposition to issuer
D—
59.3K sh
Jun 11, 2026Jun 11, 2026
traded Jun 11, 2026
+0dSEC Form 4

Evidence

5
PE
Paul ElaineDirector
MQMarqeta, Inc.
Option exercise
M—
36.3K sh
Jun 10, 2026Jun 11, 2026
traded Jun 10, 2026
+1dSEC Form 4

Evidence

5
AK
Audhya Paul K.CHIEF MEDICAL OFFICER
KALVKalVista Pharmaceuticals, Inc.
Disposition to issuer
D—
150.3K sh
Jun 11, 2026Jun 11, 2026
traded Jun 11, 2026
+0dSEC Form 4

Evidence

5
PB
Piekos BrianChief Financial Officer
KALVKalVista Pharmaceuticals, Inc.
Disposition to issuer
D—
21.7K sh
Jun 11, 2026Jun 11, 2026
traded Jun 11, 2026
+0dSEC Form 4

Evidence

5
RJ
Riese Phillip JohnDirector
RELYRemitly Global, Inc.
Option exercise
M—
9,533 sh
Jun 10, 2026Jun 11, 2026
traded Jun 10, 2026
+1dSEC Form 4

Evidence

5
PE
Paul ElaineDirector
MQMarqeta, Inc.
Grant or award
A—
52.2K sh
Jun 10, 2026Jun 11, 2026
traded Jun 10, 2026
+1dSEC Form 4

Evidence

5
SN
Sweeny NicoleChief Commercial Officer
KALVKalVista Pharmaceuticals, Inc.
Disposition to issuer
D—
100.0K sh
Jun 11, 2026Jun 11, 2026
traded Jun 11, 2026
+0dSEC Form 4

Evidence

5
AK
Audhya Paul K.CHIEF MEDICAL OFFICER
KALVKalVista Pharmaceuticals, Inc.
Disposition to issuer
D—
100.0K sh
Jun 11, 2026Jun 11, 2026
traded Jun 11, 2026
+0dSEC Form 4

Evidence

5
WG
Wright Robert G.EVP
DKDelek US Holdings, Inc.
Tax withholding
F$48K
1,024 sh
Jun 9, 2026Jun 11, 2026
traded Jun 9, 2026
+2dSEC Form 4

Evidence

5
AK
Audhya Paul K.CHIEF MEDICAL OFFICER
KALVKalVista Pharmaceuticals, Inc.
Disposition to issuer
D—
40.0K sh
Jun 11, 2026Jun 11, 2026
traded Jun 11, 2026
+0dSEC Form 4

Evidence

5
AN
Atkinson NajumaDirector
MQMarqeta, Inc.
Option exercise
M—
36.3K sh
Jun 10, 2026Jun 11, 2026
traded Jun 10, 2026
+1dSEC Form 4

Evidence

5
PB
Piekos BrianChief Financial Officer
KALVKalVista Pharmaceuticals, Inc.
Disposition to issuer
D—
100.0K sh
Jun 11, 2026Jun 11, 2026
traded Jun 11, 2026
+0dSEC Form 4

Evidence

5
AK
Audhya Paul K.CHIEF MEDICAL OFFICER
KALVKalVista Pharmaceuticals, Inc.
Disposition to issuer
D—
68.8K sh
Jun 11, 2026Jun 11, 2026
traded Jun 11, 2026
+0dSEC Form 4

Evidence

5
SJ
Sweet Alan JeffreyDirector
NKSHNATIONAL BANKSHARES INC
Grant or award
A—
221 sh
Jun 10, 2026Jun 11, 2026
traded Jun 10, 2026
+1dSEC Form 4

Evidence

5
MJ
Mirshekari Ali JohnDirector
STSensata Technologies Holding plc
Tax withholding
F$22K
439 sh
Jun 9, 2026Jun 11, 2026
traded Jun 9, 2026
+2dSEC Form 4

Evidence

5
CM
Cummings MarthaDirector
MQMarqeta, Inc.
Grant or award
A—
52.2K sh
Jun 10, 2026Jun 11, 2026
traded Jun 10, 2026
+1dSEC Form 4

Evidence

5
PB
Piekos BrianChief Financial Officer
KALVKalVista Pharmaceuticals, Inc.
Disposition to issuer
D—
55.0K sh
Jun 11, 2026Jun 11, 2026
traded Jun 11, 2026
+0dSEC Form 4

Evidence

5
CM
Cummings MarthaDirector
MQMarqeta, Inc.
Option exercise
M—
36.3K sh
Jun 10, 2026Jun 11, 2026
traded Jun 10, 2026
+1dSEC Form 4

Evidence

5
AN
Atkinson NajumaDirector
MQMarqeta, Inc.
Grant or award
A—
52.2K sh
Jun 10, 2026Jun 11, 2026
traded Jun 10, 2026
+1dSEC Form 4

Evidence

5
PB
Piekos BrianChief Financial Officer
KALVKalVista Pharmaceuticals, Inc.
Disposition to issuer
D—
93.8K sh
Jun 11, 2026Jun 11, 2026
traded Jun 11, 2026
+0dSEC Form 4

Evidence

5
SN
Sweeny NicoleChief Commercial Officer
KALVKalVista Pharmaceuticals, Inc.
Disposition to issuer
D—
93.8K sh
Jun 11, 2026Jun 11, 2026
traded Jun 11, 2026
+0dSEC Form 4

Evidence

5
AK
Audhya Paul K.CHIEF MEDICAL OFFICER
KALVKalVista Pharmaceuticals, Inc.
Disposition to issuer
D—
25.8K sh
Jun 11, 2026Jun 11, 2026
traded Jun 11, 2026
+0dSEC Form 4

Evidence

5
SJ
Schall Thomas J.Director
IMRXImmuneering Corp
Grant or award
A—
33.4K sh
Jun 11, 2026Jun 11, 2026
traded Jun 11, 2026
+0dSEC Form 4

Evidence

5
GM
Gray Jonice MDirector
VACMARRIOTT VACATIONS WORLDWIDE Corp
Grant or award
A—
118 sh
Jun 10, 2026Jun 11, 2026
traded Jun 10, 2026
+1dSEC Form 4

Evidence

5
FP
Feinberg PeterDirector
IMRXImmuneering Corp
Grant or award
A—
33.4K sh
Jun 11, 2026Jun 11, 2026
traded Jun 11, 2026
+0dSEC Form 4

Evidence

5
SN
Sweeny NicoleChief Commercial Officer
KALVKalVista Pharmaceuticals, Inc.
Disposition to issuer
D—
40.0K sh
Jun 11, 2026Jun 11, 2026
traded Jun 11, 2026
+0dSEC Form 4

Evidence

5
AK
Audhya Paul K.CHIEF MEDICAL OFFICER
KALVKalVista Pharmaceuticals, Inc.
Disposition to issuer
D—
93.8K sh
Jun 11, 2026Jun 11, 2026
traded Jun 11, 2026
+0dSEC Form 4

Evidence

5
SN
Sweeny NicoleChief Commercial Officer
KALVKalVista Pharmaceuticals, Inc.
Disposition to issuer
D—
68.8K sh
Jun 11, 2026Jun 11, 2026
traded Jun 11, 2026
+0dSEC Form 4

Evidence

4
ND
Noci DarleneChief Development Officer
NUVLNuvalent, Inc.
Option exercise · 10b5-1 plan
M—
9,315 sh
Jun 9, 2026Jun 11, 2026
traded Jun 9, 2026
+2dSEC Form 4

Evidence

4
NS
Neville Patrick SeanDirector
CRCLCircle Internet Group, Inc.
Derivative conversion · 10b5-1 plan
C—
50.0K sh
Jun 9, 2026Jun 11, 2026
traded Jun 9, 2026
+2dSEC Form 4

Evidence

1
RR
Remer Eric RichardDirector, Chief Executive Officer
EVCMEverCommerce Inc.
Open-market sale · 10b5-1 plan
SELL$106K
11.7K sh
Jun 9, 2026Jun 11, 2026
traded Jun 9, 2026
+2dSEC Form 4

Evidence

1
RR
Remer Eric RichardDirector, Chief Executive Officer
EVCMEverCommerce Inc.
Open-market sale · 10b5-1 plan
SELL$69K
7,517 sh
Jun 10, 2026Jun 11, 2026
traded Jun 10, 2026
+1dSEC Form 4

Evidence

0
ND
Noci DarleneChief Development Officer
NUVLNuvalent, Inc.
Option exercise · 10b5-1 plan
M$176K
9,315 sh
Jun 9, 2026Jun 11, 2026
traded Jun 9, 2026
+2dSEC Form 4

Evidence

0
ND
Noci DarleneChief Development Officer
NUVLNuvalent, Inc.
Option exercise · 10b5-1 plan
M$11K
10.0K sh
Jun 9, 2026Jun 11, 2026
traded Jun 9, 2026
+2dSEC Form 4

Evidence

0
ND
Noci DarleneChief Development Officer
NUVLNuvalent, Inc.
Option exercise · 10b5-1 plan
M—
685 sh
Jun 9, 2026Jun 11, 2026
traded Jun 9, 2026
+2dSEC Form 4

Evidence

0
BS
Baig SaqibInterim CFO, CAO
PTONPELOTON INTERACTIVE, INC.
Open-market sale · 10b5-1 plan
SELL$28K
5,000 sh
Jun 9, 2026Jun 11, 2026
traded Jun 9, 2026
+2dSEC Form 4

Evidence

0
ND
Noci DarleneChief Development Officer
NUVLNuvalent, Inc.
Option exercise · 10b5-1 plan
M—
10.0K sh
Jun 9, 2026Jun 11, 2026
traded Jun 9, 2026
+2dSEC Form 4

Evidence

0
NS
Neville Patrick SeanDirector
CRCLCircle Internet Group, Inc.
Derivative conversion · 10b5-1 plan
C—
50.0K sh
Jun 9, 2026Jun 11, 2026
traded Jun 9, 2026
+2dSEC Form 4

Evidence

0
ND
Noci DarleneChief Development Officer
NUVLNuvalent, Inc.
Option exercise · 10b5-1 plan
M$4,720
685 sh
Jun 9, 2026Jun 11, 2026
traded Jun 9, 2026
+2dSEC Form 4

Evidence